Myocarditis, hepatitis, and pancreatitis in a patient with coxsackievirus A4 infection: A case report

Virology Journal

Volumn 11, Issue 1, 2014, Pages

  Akuzawa, Nobuhiro ^a   Harada, Naoyuki ^a   Hatori, Takashi ^a   Imai, Kunihiko ^a   Kitahara, Yonosuke ^a   Sakurai, Shinji ^a   Kurabayashi, Masahiko ^b  

^a Social Insurance Gunma Chuo General Hospital   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Coxsackievirus; Liver dysfunction; Myocarditis; Pancreatitis; Rectal cancer

Indexed keywords

AMIODARONE; AMLODIPINE; AMYLASE; ANTIHYPERTENSIVE AGENT; ATRIAL NATRIURETIC FACTOR; AZOSEMIDE; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; CEFTRIAXONE; CREATINE KINASE; CREATINE KINASE MB; DOPAMINE; FLUOROURACIL; FOLINIC ACID; FUROSEMIDE; GABEXATE MESILATE; HEPARIN; LIVER ENZYME; LOSARTAN; OXALIPLATIN; SPIRONOLACTONE; TROPONIN I; WARFARIN;

ADULT; ANTIBODY TITER; ARTICLE; BRADYCARDIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMPLETE HEART BLOCK; COUGHING; COXSACKIE VIRUS A; COXSACKIE VIRUS INFECTION; COXSACKIEVIRUS A4 INFECTION; CREATINE KINASE BLOOD LEVEL; CYANOSIS; DIARRHEA; DYSPNEA; ELECTROCARDIOGRAPHY; ELEVATED BLOOD PRESSURE; ENZYMURIA; EPIGASTRIC PAIN; EXTERNAL JUGULAR VEIN; FATIGUE; FEVER; FLU LIKE SYNDROME; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE BIOPSY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HEPATITIS; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTRANSAMINASEMIA; HYPOKINESIA; KIDNEY FAILURE; LEG EDEMA; LEUKOCYTOSIS; LIVER DYSFUNCTION; LIVER METASTASIS; LOW DRUG DOSE; LUNG CONGESTION; LYMPH VESSEL METASTASIS; LYMPHOCYTIC INFILTRATION; MALE; MIDDLE AGED; MONOMORPHIC VENTRICULAR TACHYCARDIA; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PANCREATITIS; PARTIAL HEPATECTOMY; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; RECTUM ANTERIOR RESECTION; RECTUM CANCER; RETROPERITONEAL FAT; SORE THROAT; SWELLING; T LYMPHOCYTE; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION; VEIN DISEASE; VIRUS MYOCARDITIS;

COXSACKIEVIRUS;

COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; MYOCARDITIS; PANCREATITIS; RECTAL NEOPLASMS;

EID: 84892381904     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-11-3     Document Type: Article

References (24)

1. Myocarditis. Cooper LT, N Engl J Med 2009 360 1526 1538 10.1056/NEJMra0800028 19357408
2. Myocarditis: current trends in diagnosis and treatment. Magnani JW, Dec GW, Circulation 2006 113 876 890 10.1161/CIRCULATIONAHA.105.584532 16476862
3. Myocarditis. Feldman AM, McNamara D, N Engl J Med 2000 343 1388 1398 10.1056/NEJM200011093431908 11070105
4. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. Dec GW Jr, Palacios IF, Fallon JT, Aretz HT, Mills J, Lee DC, Johnson RA, N Engl J Med 1985 312 885 890 10.1056/NEJM198504043121404 3974674
5. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Mahrhodlt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Sechtem U, Circulation 2006 114 1581 1590 10.1161/CIRCULATIONAHA.105.606509 17015795
6. Viral causes of human myocarditis. Andréoletti L, Lévêque N, Boulagnon C, Brasselet C, Fornes P, Arch Cardiovasc Dis 2009 102 559 568 10.1016/j.acvd.2009.04.010 19664576
7. Myocarditis: diagnosis and treatment. Guglin M, Nallamshetty L, Curr Treat Options Cardiovasc Med 2012 14 637 651 10.1007/s11936-012-0204-7 22927087
8. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP, Circulation 2005 112 1965 1970 10.1161/ CIRCULATIONAHA.105.548156 16172268
9. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC, Circulation 1994 89 2582 2589 10.1161/01.CIR.89.6.2582 8205668
10. Viral myocarditis: a review. Woodruff JF, Am J Pathol 1980 101 425 484 6254364
11. Pathogenesis of virus-induced diabetes in mice. See DM, Tilles JG, J Infect Dis 1995 171 1131 1138 10.1093/infdis/171.5.1131 7751687
12. Meta-analysis of the association of enteroviruses with human heart disease. Baboonian C, Treasure T, Heart 1997 78 539 543 9470867
13. Enterovirus sequences resembling coxsackievirus A2 detected in stool and spleen from a girl with fetal myocarditis. Bendig JW, O'Brien PS, Muir P, Porter HJ, Caul EO, J Med Virol 2001 64 482 486 10.1002/jmv.1075 11468733
14. Cardiac, pancreatic, and liver abnormalities in a patient with coxsackie-B infection. Coplan NL, Atallah V, Mediratta S, Bruno MS, DePasquale NP, Am J Med 1996 101 325 326 10.1016/S0002-9343(97)89436-3 8873496
15. Acute fulminant, fatal coxsackie B virus infection: a report of two cases. Lau G, Ann Acad Med Singapore 1994 23 917 920 7741514
16. Differential behavior in pancreas and heart two coxsakievirus B3 variants. Gomez RM, Cui X, Castagnino CG, Berria MI, Intervirology 1993 36 153 160 8150596
17. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Foulis AK, Farguharson MA, Cameron SO, McGill M, Schönke H, Kandolf R, Diabetologia 1990 33 290 298 10.1007/BF00403323 2376300
18. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor -coxsackie-adenovirus receptor pathway. Shi Y, Fukuoka M, Li G, Liu Y, Chen M, Konviser M, Chen X, Opavsky MA, Liu PP, Circulation 2010 121 2624 2634 10.1161/CIRCULATIONAHA.109. 893248 20530002
19. Adoptive transfer of regulatory T cells protect against Coxsackievirus B3-induced cardiac fibrosis. Cao Y, Xu W, Xiong S, PLoS One 2013 6 7455
20. Home sweet home: the tumor microenviroment as a haven for regulatory T cells. Ondondo B, Jones E, Godkin A, Gallmore A, Front Immunol 2013 4 197 23874342
21. Behavior of circulating CD4 + CD25 + Foxp3+ regulatory T cells in colon cancer patients undergoing surgery. Sellito A, Galizia G, De Fanis U, Lieto E, Zamboli A, Orditura M, De Vita F, Giunta R, Lucivero G, Romano C, J Clin Immunol 2011 31 1095 1104 10.1007/s10875-011-9585-8 21915633
22. Natural regulatory T cells and persistent viral infection. Li S, Gowans EJ, Chougnet C, Plebanski M, Dittmer U, J Virol 2008 82 21 30 10.1128/JVI.01768-07 17855537
23. Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy. Miteva K, Van Linthout S, Volk HD, Tschöpe C, Stem Cells Int 2013 2013 353097 doi:10.1155/2013/353097 23853610
24. Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis. Savvatis K, Van Linthout S, Miteva K, Pappritz K, Westermann D, Schefold JC, Fusch G, Weithäuser A, Rauch U, Becher M, Klingel K, Ringe J, Kurtz A, Schultheiss HP, Tschöpe C, PLoS One 2012 7 41047 10.1371/journal.pone.0041047 22815907